Corrie Gallant-Behm, PhD

Senior Director, Research at Atalanta Therapeutics

Speaker

Corrie Gallant-Behm is Senior Director of Research at Atalanta Therapeutics, focusing on the discovery and development of divalent siRNAs (di-siRNAs) for the treatment of neurological and neurodegenerative disorders. Prior to joining Atalanta, Corrie held scientific and leadership roles at miRagen Therapeutics, focusing on oligonucleotide therapeutic development in fibrosis, wound healing, ophthalmology, musculoskeletal disorders, cardiovascular disease, oncology, and sensorineural diseases.

Corrie holds a BSc and Ph.D. in molecular biology from the University of Calgary and a Master of Science in Quality Assurance and Regulatory Sciences from Northeastern University. Corrie completed postdoctoral fellowships at the University of Colorado Boulder, and Northeastern University.